274 related articles for article (PubMed ID: 30584533)
1. Reducing Blood Loss in Revision Total Hip and Knee Arthroplasty: Tranexamic Acid Is Effective in Aseptic Revisions and in Second-Stage Reimplantations for Periprosthetic Infection.
Reichel F; Peter C; Ewerbeck V; Egermann M
Biomed Res Int; 2018; 2018():3891870. PubMed ID: 30584533
[TBL] [Abstract][Full Text] [Related]
2. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia.
Huang ZY; Huang Q; Zeng HJ; Ma J; Shen B; Zhou ZK; Pei FX
BMC Musculoskelet Disord; 2019 Sep; 20(1):402. PubMed ID: 31481049
[TBL] [Abstract][Full Text] [Related]
3. Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty.
George DA; Sarraf KM; Nwaboku H
Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):129-33. PubMed ID: 24756178
[TBL] [Abstract][Full Text] [Related]
4. Intravenous tranexamic acid safely and effectively reduces transfusion rates in revision total hip arthroplasty.
Hines JT; Hernandez NM; Amundson AW; Pagnano MW; Sierra RJ; Abdel MP
Bone Joint J; 2019 Jun; 101-B(6_Supple_B):104-109. PubMed ID: 31146563
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of Efficacy of Systemic Administration of Tranexamic Acid (Exacyl) in Total Hip and Knee Arthroplasty - Prospective Cohort Study].
Mannová J; Kubát P; Pospíchal M; Longin P
Acta Chir Orthop Traumatol Cech; 2019; 86(2):118-123. PubMed ID: 31070570
[TBL] [Abstract][Full Text] [Related]
6. Topical Tranexamic Acid Use in Knee Periprosthetic Joint Infection Is Safe and Effective.
Waddell BS; Zahoor T; Meyer M; Ochsner L; Chimento G
J Knee Surg; 2016 Jul; 29(5):423-9. PubMed ID: 26408993
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic Acid in Hip and Knee Arthroplasty.
Melvin JS; Stryker LS; Sierra RJ
J Am Acad Orthop Surg; 2015 Dec; 23(12):732-40. PubMed ID: 26493971
[TBL] [Abstract][Full Text] [Related]
8. Reduction of Blood Loss by Tranexamic Acid Following Total Hip and Knee Arthroplasty: A Meta-Analysis.
Gianakos AL; Hurley ET; Haring RS; Yoon RS; Liporace FA
JBJS Rev; 2018 May; 6(5):e1. PubMed ID: 29738409
[TBL] [Abstract][Full Text] [Related]
9. Projections and Epidemiology of Revision Hip and Knee Arthroplasty in the United States to 2030.
Schwartz AM; Farley KX; Guild GN; Bradbury TL
J Arthroplasty; 2020 Jun; 35(6S):S79-S85. PubMed ID: 32151524
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tranexamic acid in unilateral major revision total hip arthroplasty.
Mei L; Li H; Zhu W; Luo Y; Mao X
Ann Palliat Med; 2020 Sep; 9(5):2466-2473. PubMed ID: 32921073
[TBL] [Abstract][Full Text] [Related]
11. Topical Tranexamic Acid in Revision Total Knee Arthroplasty Reduces Transfusion Rates and May Be Associated With Earlier Recovery.
Huerfano E; Huerfano M; Shanaghan KA; Gonzalez Della Valle A
J Arthroplasty; 2019 Jul; 34(7S):S249-S255. PubMed ID: 30448325
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Tranexamic Acid Safely and Effectively Reduces Transfusion Rates in Revision Total Knee Arthroplasties.
Hines JT; Petis SM; Amundson AW; Pagnano MW; Sierra RJ; Abdel MP
J Bone Joint Surg Am; 2020 Mar; 102(5):381-387. PubMed ID: 31977819
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma D-dimer concentration has higher efficacy for the diagnosis of periprosthetic joint infection of the knee than of the hip-A single-center, retrospective study.
Grzelecki D; Walczak P; Grajek A; Szostek M; Dudek P; Bartosz P; Olewnik Ł; Czubak-Wrzosek M; Marczak D; Tyrakowski M
J Orthop Res; 2021 Feb; 39(2):291-298. PubMed ID: 33098596
[TBL] [Abstract][Full Text] [Related]
14. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
[TBL] [Abstract][Full Text] [Related]
15. Intravenous tranexamic acid is associated with safe reduced blood loss and transfusion rate in one-stage exchange for infected hip arthroplasty.
Abdelaziz H; Chaabene A; Schulmeyer J; Gehrke T; Haasper C; Hawi N; Citak M
Jt Dis Relat Surg; 2021; 32(1):17-21. PubMed ID: 33463413
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the Burden of Revision Total Joint Arthroplasty for Periprosthetic Infection.
Kamath AF; Ong KL; Lau E; Chan V; Vail TP; Rubash HE; Berry DJ; Bozic KJ
J Arthroplasty; 2015 Sep; 30(9):1492-7. PubMed ID: 25865815
[TBL] [Abstract][Full Text] [Related]
17. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness and safety of tranexamic acid in total hip or knee arthroplasty: a meta-analysis of 2720 cases.
Wei Z; Liu M
Transfus Med; 2015 Jun; 25(3):151-62. PubMed ID: 26033447
[TBL] [Abstract][Full Text] [Related]
20. Age-Adjusted Modified Frailty Index Predicts 30-Day Complications and Mortality in Aseptic Revision Total Hip and Knee Arthroplasty.
Zamanzadeh RS; Seilern Und Aspang JRM; Schwartz AM; Martin JR; Premkumar A; Wilson JM
J Arthroplasty; 2024 Jan; 39(1):198-205. PubMed ID: 37380143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
